Clinical data show that CD36+ cells correlate with greater invasion and poor prognosis in several carcinomas, and CD36 inhibition also impairs metastasis in breast cancer-derived tumors and human melanoma [133]. The gene discussed is CD36; the disease is breast carcinoma.